UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 9, 2026
Accession Number:
0001193125-26-005780
Submission Type:
POS AM
CIK:
0001610618
Company Name:
Cidara Therapeutics, Inc.
File Number:
333-225787